{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:03:07Z","timestamp":1761886987515,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.oftale.2023.08.008","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T11:33:09Z","timestamp":1693049589000},"page":"646-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of experimental treatments for patients with retinitis pigmentosa"],"prefix":"10.1016","volume":"98","author":[{"given":"L.L.","family":"Lozano B.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.A.","family":"Cervantes A.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftale.2023.08.008_bib0005","unstructured":"Road P-5555 6925 OM, #701, Columbia, et al. What Is Retinitis Pigmentosa? n.d. Available from: https:\/\/www.fightingblindness.org\/diseases\/retinitis-pigmentosa [Last accessed: 6\/23\/2023]."},{"issue":"1","key":"10.1016\/j.oftale.2023.08.008_bib0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/IIO.0000000000000256","article-title":"Retinitis pigmentosa: review of current treatment","volume":"59","author":"Wang","year":"2019","journal-title":"Int Ophthalmol Clin"},{"issue":"6\u20137","key":"10.1016\/j.oftale.2023.08.008_bib0015","first-page":"607","article-title":"[Gene therapy for retinitis pigmentosa]","volume":"36","author":"Ducloyer","year":"2020","journal-title":"Med Sci MS"},{"key":"10.1016\/j.oftale.2023.08.008_bib0020","unstructured":"Anonymous. Retinitis Pigmentosa: Recent Advances and Future Directions in Diagnosis and Management - PubMed. n.d. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30234647\/ [Last accessed: 10\/31\/2022]."},{"issue":"1","key":"10.1016\/j.oftale.2023.08.008_bib0025","first-page":"25","article-title":"Retinosis Pigmentaria","volume":"1","author":"Palacios-Andrade","year":"2019","journal-title":"Rev Estud CEUS Cienc Estud Unidad Salud"},{"issue":"8","key":"10.1016\/j.oftale.2023.08.008_bib0030","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s10103-020-03036-9","article-title":"Laser treatment in retinitis pigmentosa-a review","volume":"35","author":"Gaw\u0119cki","year":"2020","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.oftale.2023.08.008_bib0035","unstructured":"Dyonne T Hartong, Eliot L Berson, Thaddeus P Dryja. Retinitis Pigmentosa - PubMed. n.d. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17113430\/ [Last accessed: 12\/4\/2022]."},{"issue":"4","key":"10.1016\/j.oftale.2023.08.008_bib0040","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/08164622.2021.1880863","article-title":"Gene therapy for inherited retinal diseases: progress and possibilities","volume":"104","author":"Hu","year":"2021","journal-title":"Clin Exp Optom"},{"issue":"2","key":"10.1016\/j.oftale.2023.08.008_bib0045","first-page":"73","article-title":"[Retinitis pigmentosa]","volume":"75","author":"Bruninx","year":"2020","journal-title":"Rev Med Liege"},{"key":"10.1016\/j.oftale.2023.08.008_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2018.11.001","article-title":"Transplantation of photoreceptors into the degenerative retina: current state and future perspectives","volume":"69","author":"Gasparini","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oftale.2023.08.008_bib0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.preteyeres.2018.11.003","article-title":"Stemming retinal regeneration with pluripotent stem cells","volume":"69","author":"Jin","year":"2019","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"10.1016\/j.oftale.2023.08.008_bib0060","first-page":"175","article-title":"Retinitis pigmentosa in Ontario - a survey","volume":"18","author":"Macrae","year":"2019","journal-title":"Birth Defects Orig Artic Ser"},{"key":"10.1016\/j.oftale.2023.08.008_bib0065","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1146\/annurev-pharmtox-010919-023245","article-title":"Retinal pigment epithelium replacement therapy for age-related macular degeneration: are we there yet?","volume":"60","author":"Sharma","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.oftale.2023.08.008_bib0070","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.2147\/OPTH.S370032","article-title":"Current and future treatment of retinitis pigmentosa","volume":"16","author":"Cross","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.oftale.2023.08.008_bib0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00347-012-2555-6","article-title":"Retinitis pigmentosa - a review. Pathogenesis, guidelines for diagnostics and perspectives","volume":"109","author":"Zobor","year":"2012","journal-title":"Ophthalmologe"},{"issue":"11","key":"10.1016\/j.oftale.2023.08.008_bib0080","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1136\/bjophthalmol-2018-313669","article-title":"Classification of disease severity in retinitis pigmentosa","volume":"103","author":"Iftikhar","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.oftale.2023.08.008_bib0085","doi-asserted-by":"crossref","first-page":"432","DOI":"10.18502\/jovr.v16i3.9439","article-title":"Fundus autofluorescence and clinical applications","volume":"16","author":"Pole","year":"2021","journal-title":"J Ophthalmic Vis Res"},{"issue":"8","key":"10.1016\/j.oftale.2023.08.008_bib0090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/21678707.2018.1508340","article-title":"Voretigene neparvovec-rzyl for the treatment of biallelic RPE65 mutation-associated retinal dystrophy","volume":"6","author":"Russell","year":"2018","journal-title":"Expert Opin Orphan Drugs"},{"issue":"5","key":"10.1016\/j.oftale.2023.08.008_bib0095","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/14656566.2018.1448060","article-title":"Pharmacotherapy of retinal disease with visual cycle modulators","volume":"19","author":"Hussain","year":"2018","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"10.1016\/j.oftale.2023.08.008_bib0100","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1167\/iovs.16-19300","article-title":"Intravitreal injection of proinsulin-loaded microspheres delays photoreceptor cell death and vision loss in the rd10 mouse model of retinitis pigmentosa","volume":"57","author":"Isiegas","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"year":"2022","series-title":"Primer paciente tratado con una nueva mol\u00e9cula peque\u00f1a (EA-2353) para todos los tipos de retinosis pigmentaria","author":"Carlos","key":"10.1016\/j.oftale.2023.08.008_bib0105"},{"key":"10.1016\/j.oftale.2023.08.008_bib0110","unstructured":"Anonymous. Dose Escalation Study to Evaluate the Safety\/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa - Full Text View - ClinicalTrials.Gov. n.d. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05392751 [Last accessed: 6\/24\/2023]."},{"issue":"19","key":"10.1016\/j.oftale.2023.08.008_bib0115","article-title":"Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa","volume":"13","author":"Sanchez-Cruz","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.oftale.2023.08.008_bib0120","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jep.2019.03.023","article-title":"Delay of cone degeneration in retinitis pigmentosa using a 12-month treatment with Lycium barbarum supplement","volume":"236","author":"Chan","year":"2019","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.oftale.2023.08.008_bib0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s42003-020-01594-w","article-title":"Optogenetic therapy: high spatiotemporal resolution and pattern discrimination compatible with vision restoration in non-human primates","volume":"4","author":"Gauvain","year":"2021","journal-title":"Commun Biol"},{"issue":"6\u20137","key":"10.1016\/j.oftale.2023.08.008_bib0130","first-page":"600","article-title":"[Photoreceptor cell transplantation for future treatment of retinitis pigmentosa]","volume":"36","author":"Goureau","year":"2020","journal-title":"Med Sci MS"},{"issue":"10","key":"10.1016\/j.oftale.2023.08.008_bib0135","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/13543784.2020.1804853","article-title":"Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases","volume":"29","author":"Xue","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.oftale.2023.08.008_bib0140","unstructured":"Anonymous. An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa - Full Text View - ClinicalTrials.Gov. n.d. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05085964 [Last accessed: 6\/24\/2023]."},{"issue":"8","key":"10.1016\/j.oftale.2023.08.008_bib0145","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1089\/hum.2018.244","article-title":"Development of a molecularly stable gene therapy vector for the treatment of RPGR-associated X-linked retinitis pigmentosa","volume":"30","author":"Giacalone","year":"2019","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1016\/j.oftale.2023.08.008_bib0150","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3390\/ijms22042092","article-title":"Gene correction recovers phagocytosis in retinal pigment epithelium derived from retinitis pigmentosa-human-induced pluripotent stem cells","volume":"22","author":"Artero-Castro","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.oftale.2023.08.008_bib0155","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1167\/iovs.18-24621","article-title":"Neuroprotective effects of FGF2 and minocycline in two animal models of inherited retinal degeneration","volume":"59","author":"Di Pierdomenico","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oftale.2023.08.008_bib0160","unstructured":"Anonymous. Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene - Full Text View - ClinicalTrials.Gov. n.d. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03780257 [Last accessed: 6\/23\/2023]."},{"issue":"4","key":"10.1016\/j.oftale.2023.08.008_bib0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/tvst.8.4.19","article-title":"Retinal laser therapy preserves photoreceptors in a rodent model of MERTK-related retinitis pigmentosa","volume":"8","author":"Kang","year":"2019","journal-title":"Transl Vis Sci Technol"},{"issue":"11","key":"10.1016\/j.oftale.2023.08.008_bib0170","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1167\/iovs.14-15458","article-title":"Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing","volume":"55","author":"Oishi","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.oftale.2023.08.008_bib0175","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/81555","article-title":"Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa","volume":"26","author":"Gal","year":"2000","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.oftale.2023.08.008_bib0180","doi-asserted-by":"crossref","first-page":"11312","DOI":"10.1038\/s41598-018-29631-z","article-title":"Long-term rescue of photoreceptors in a rodent model of retinitis pigmentosa associated with MERTK mutation","volume":"8","author":"Lorach","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.oftale.2023.08.008_bib0185","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1007\/s12325-020-01308-y","article-title":"Management of retinitis pigmentosa via platelet-rich plasma or combination with electromagnetic stimulation: retrospective analysis of 1-year results","volume":"37","author":"Arslan","year":"2020","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.oftale.2023.08.008_bib0190","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1111\/aos.13581","article-title":"Randomized controlled trial of electro-stimulation therapies to modulate retinal blood flow and visual function in retinitis pigmentosa","volume":"96","author":"Bittner","year":"2018","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"2","key":"10.1016\/j.oftale.2023.08.008_bib0195","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00417-017-3858-8","article-title":"Longevity of visual improvements following transcorneal electrical stimulation and efficacy of retreatment in three individuals with retinitis pigmentosa","volume":"256","author":"Bittner","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"10.1016\/j.oftale.2023.08.008_bib0200","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/jop.2020.0017","article-title":"Effect of transcorneal electrical stimulation on patients with retinitis pigmentosa","volume":"36","author":"Kahraman","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.oftale.2023.08.008_bib0205","doi-asserted-by":"crossref","first-page":"741","DOI":"10.55730\/1300-0144.5368","article-title":"Outcomes of transcorneal electrical stimulation therapy in the early stages of retinitis pigmentosa","volume":"52","author":"Demir","year":"2022","journal-title":"Turk J Med Sci"},{"issue":"3","key":"10.1016\/j.oftale.2023.08.008_bib0210","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000505001","article-title":"Transcorneal electrical stimulation for the treatment of retinitis pigmentosa: a multicenter safety study of the OkuStim (R) system (TESOLA-Study)","volume":"63","author":"Jolly","year":"2020","journal-title":"Ophthalmic Res"},{"issue":"20","key":"10.1016\/j.oftale.2023.08.008_bib0215","doi-asserted-by":"crossref","first-page":"10140","DOI":"10.1073\/pnas.1901787116","article-title":"Soluble CX3CL1 gene therapy improves cone survival and function in mouse models of retinitis pigmentosa","volume":"116","author":"Wang","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19\u201320","key":"10.1016\/j.oftale.2023.08.008_bib0220","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1089\/hum.2021.121","article-title":"In vivo potency testing of subretinal rAAV5.hCNGB1 gene therapy in the Cngb1 knockout mouse model of retinitis pigmentosa","volume":"32","author":"Wagner","year":"2021","journal-title":"Hum Gene Ther"},{"issue":"7","key":"10.1016\/j.oftale.2023.08.008_bib0225","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3349\/ymj.2022.63.7.701","article-title":"Short-term outcomes of the first in vivo gene therapy for RPE65-mediated retinitis pigmentosa","volume":"63","author":"Kwak","year":"2022","journal-title":"Yonsei Med J"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217357942300141X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217357942300141X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:29:54Z","timestamp":1761881394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S217357942300141X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S217357942300141X"],"URL":"https:\/\/doi.org\/10.1016\/j.oftale.2023.08.008","relation":{},"ISSN":["2173-5794"],"issn-type":[{"type":"print","value":"2173-5794"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of experimental treatments for patients with retinitis pigmentosa","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftale.2023.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2023.08.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Oftalmolog\u00eda.","name":"copyright","label":"Copyright"}]}}